Thursday, June 19, 2014
Publication and contact
IL-17; IL-17 receptor (IL17R;
Human sample and mouse
studies suggest inhibiting IL-17 signaling could help treat pancreatic
cancer. Chronic pancreatitis accelerates pancreatic cancer, and chronic
inflammation can induce pancreatic intraepithelial neoplasias (PanINs). In
human tissue arrays, IL17R expression was greater in pancreatic lesions,
including PanINs, than normal acinar tissue. In a mouse model of inducible
pancreatitis that progresses to PanIN, Il-17 was expressed in Cd4+ T cells, and depletion of Cd4+ T cells delayed progression. In the mice, a
cocktail of anti-IL17R and anti-IL-17 mAbs decreased PanINs on the pancreas
surface and the number of advanced PanINs compared with saline. Next steps
include neutralizing IL-17 signaling in more advanced metastatic disease
models and identifying patients that would benefit from IL-17 inhibition.
plc and Kyowa
Hakko Kirin Co. Ltd. have brodalumab,
a humanized mAb against IL17R, in Phase III or earlier testing to treat
autoimmune and inflammatory indications.
At least seven companies have antibodies against IL-17 in Phase II or earlier
testing to treat various indications.
Published online June 19, 2014
status not applicable
McAllister, F. et al.
published online May 12, 2014;
Contact: Steven D. Leach, The Johns Hopkins University, Baltimore,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]